2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …

C Vrints, F Andreotti, KC Koskinas… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Metabolic syndrome

IJ Neeland, S Lim, A Tchernof, A Gastaldelli… - Nature Reviews …, 2024 - nature.com
The metabolic syndrome (MetS) is a multiplex modifiable risk factor for cardiovascular
disease, type 2 diabetes mellitus and other health outcomes, and is a major challenge to …

Ceramides and other sphingolipids as drivers of cardiovascular disease

RH Choi, SM Tatum, JD Symons… - Nature Reviews …, 2021 - nature.com
Increases in calorie consumption and sedentary lifestyles are fuelling a global pandemic of
cardiometabolic diseases, including coronary artery disease, diabetes mellitus …

Ceramides in metabolism: key lipotoxic players

B Chaurasia, SA Summers - Annual review of physiology, 2021 - annualreviews.org
The global prevalence of metabolic diseases such as type 2 diabetes mellitus,
steatohepatitis, myocardial infarction, and stroke has increased dramatically over the past …

Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial

S Liu, D D'Amico, E Shankland, S Bhayana… - JAMA network …, 2022 - jamanetwork.com
Importance Aging is associated with a decline in mitochondrial function and reduced
exercise capacity. Urolithin A is a natural gut microbiome–derived food metabolite that has …

Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease

AM Poss, JA Maschek, JE Cox… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Ceramides are sphingolipids that play causative roles in diabetes and heart
disease, with their serum levels measured clinically as biomarkers of cardiovascular disease …

Recent advances in analytical strategies for mass spectrometry-based lipidomics

T Xu, C Hu, Q Xuan, G Xu - Analytica chimica acta, 2020 - Elsevier
Lipids are vital biological molecules and play multiple roles in cellular function of
mammalian organisms such as cellular membrane anchoring, signal transduction, material …

Genome-wide association analysis of plasma lipidome identifies 495 genetic associations

L Ottensmann, R Tabassum, SE Ruotsalainen… - Nature …, 2023 - nature.com
The human plasma lipidome captures risk for cardiometabolic diseases. To discover new
lipid-associated variants and understand the link between lipid species and cardiometabolic …

Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential

A Zietzer, P Düsing, L Reese, G Nickenig… - … , and Vascular Biology, 2022 - Am Heart Assoc
Growing evidence suggests that ceramides play an important role in the development of
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …

Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases

MB Schulze, AM Minihane, RNM Saleh… - The Lancet Diabetes & …, 2020 - thelancet.com
Prospective observational studies support the use of long-chain omega-3 polyunsaturated
fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; …